SEC Filing Analysis: QUEST DIAGNOSTICS INC

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director at Quest Diagnostics has filed a Form 144, signaling an intent to sell approximately $270,317 worth of common stock.
• Market Impact: The transaction is of very low materiality relative to the company's $21.29 billion market capitalization and is unlikely to have any impact on the stock price.

Company Information

Field	Value
Company	QUEST DIAGNOSTICS INC
Ticker Symbol	Not provided in filing (trades on NYSE)
CIK	0001022079
Industry	Medical Laboratories

Insider Information

Field	Value
Name	PFEIFFER GARY M
CIK	0001127304
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	144 (Notice of Proposed Sale)
Transaction Date	2025-10-22 (Approximate Sale Date)
Transaction Code	S (Sale)
Security Type	Common
Shares Involved	1,482
Price Per Share	$182.40 (Calculated)
Total Value	$270,316.80
Shares Owned After	Not disclosed in filing
Ownership Type	Not disclosed in filing

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$270,316.80
% of Market Cap	0.0013%
Shares Transacted	1,482
% of Shares Outstanding	0.0013%
Post-Transaction Ownership	Not available
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a large-cap company with a market capitalization of $21.29 billion, this transaction of approximately $270k is financially insignificant.
• Ownership Concentration: The number of shares being sold is a negligible fraction of the total 111.8 million shares outstanding. The impact on insider ownership concentration is minimal.
• Dilution Impact: Not applicable, as this is a sale of existing shares, not an issuance of new equity.
• Transaction Significance: The sale represents a tiny fraction of both the company's market value (0.0013%) and its public float (0.0013%). It falls far below the thresholds for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is too small to be considered a signal of the insider's confidence in the company. It is most likely related to personal portfolio diversification, tax planning, or liquidity needs.

Volume & Sentiment

• Expected Volume Impact: None. The trade size is trivial compared to the stock's average daily trading volume.
• Sentiment Indicator: Neutral. The market will likely ignore this filing due to its low value and routine nature.

Investment Insights

Positive Market Indicators

• No positive indicators can be derived from this filing.

Risk Factors

• No significant risk factors are highlighted by this routine insider sale.

Key Takeaways

1. A director is planning a minor sale of stock.
2. The transaction's value is immaterial to a company of Quest's size.
3. This filing does not provide any meaningful signal about the company's future prospects.

Additional Context

Transaction Notes

• Source of Shares: The shares to be sold were acquired on May 16, 2025, through the vesting of restricted stock as part of the director's compensation.
• Filing Type: Form 144 is a notice of intent to sell restricted securities. The sale may occur within the next 90 days.
• Market Environment: The filing is a routine disclosure and not tied to any specific market event.